Researcher profile
Cathryn M. Lewis
Affiliations
Organizations
King's College Londonauthorship · GBMaastricht Universityauthorship · NLNational Institute for Health and Care Researchauthorship · GBNIHR Maudsley Biomedical Research Centreauthorship · GBNIHR Maudsley Dementia Biomedical Research Unitauthorship · GBSouth London and Maudsley NHS Foundation Trustauthorship · GBUniversity of Hong Kongauthorship · HK
Public evidence
8 connected articles
Impact of depression on treatment progression in type 2 diabetes: A UK retrospective cohort study using the Clinical Practice Research Datalink Aurum database2025 · medRxivWhat's UPDOG? A novel tool for trans-ancestral polygenic score prediction2023 · medRxivThe impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMCDaily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open AccessThe continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open AccessStudying individual risk factors for self-harm in the UK Biobank: A polygenic scoring and Mendelian randomisation study.2020 · PubMed Central Open AccessThe Maudsley environmental risk score for psychosis.2020 · PubMed Central Open AccessThe contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.2019 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.